omniture
Samsung Biologics Co. Ltd.

Latest News

Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment

SONGDO, South Korea, April 5, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) entered into a str...

2020-04-06 08:00 1162

Samsung Biologics expands leadership for CDO business

SONGDO, South Korea, March 30, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has appointedEun ...

2020-03-30 21:00 1526

Samsung Biologics Adds Greater Expertise and Diversity to Its Board

SONGDO, South Korea, March 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced the app...

2020-03-20 20:00 2486

Samsung Biologics expands presence in Greater China Region with CDO partnership for Alzheimer's candidate

SONGDO, South Korea, March 16, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) entered into a co...

2020-03-17 08:04 1479

Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug

SONGDO, South Korea, March 2, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and STCube announc...

2020-03-03 03:00 1305

Samsung Biologics Confirms 'No Impact' of COVID-19 with Business Continuity Plan in Effect

SONGDO, South Korea, Feb. 24, 2020 /PRNewswire/ -- Samsung Biologics has been monitoring the COVID-...

2020-02-27 15:49 1588

Samsung Biologics Reports 64% Jump in FY19 Earnings, Sees Global Expansion in 2020

INCHEON, South Korea, Feb. 4, 2020 /PRNewswire/ -- Samsung Biologics, a pharmaceutical Contract M...

2020-02-04 13:50 1077
12345